Herpes simplex virus type-1 latency-associated transcript-induced immunoreactivity of substance P in trigeminal neurons is reversed by bone morphogenetic protein-7

Neuroscience Letters

Volumn 413, Issue 1, 2007, Pages 31-35

  Hamza, Mohamed A ^a   Higgins, Dennis M ^a   Ruyechan, William T ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

BMP7; Herpes simplex virus type 1; Latency associated transcript; Substance P; Trigeminal neurons

Indexed keywords

LATENCY ASSOCIATED PEPTIDE; OSTEOGENIC PROTEIN 1; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOREACTIVITY; LATENT PERIOD; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; RAT; REGULATORY MECHANISM; RETROGRADE NERVE FIBER TRANSPORT; SENSORY NERVE CELL; TRANSCRIPTION REGULATION; TRIGEMINAL NERVE; VIRAL GENETICS; VIRUS INFECTIVITY;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION, VIRAL; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; NEURONS; RATS; SUBSTANCE P; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRIGEMINAL GANGLION; VIRUS LATENCY;

EID: 33846456303     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.11.063     Document Type: Article

References (20)

1. Brain S.D., and Cox H.M. Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br. J. Pharmacol. 147 Suppl. 1 (2006) S202-S211
2. Cao Y.Q., Mantyh P.W., Carlson E.J., Gillespie A.M., Epstein C.J., and Basbaum A.I. Primary afferent tachykinins are required to experience moderate to intense pain. Nature 392 (1998) 390-394
3. Dalziel R.G., Bingham S., Sutton D., Grant D., Champion J.M., Dennos S.A., Quinn J.P., Bountra C., and Mark M.A. Allodynia in rats infected with varicella zoster virus-a small animal model for post-herpetic neuralgia. Brain. Res. Rev. 46 (2004) 234-242
4. Deatly A.M., Spivack J.G., Lavi E., and Fraser N.W. RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 3204-3208
5. Farrell M.J., Dobson A.T., and Feldman L.T. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 790-794
6. Gonzales G.R. Postherpes simplex type 1 neuralgia simulating postherpetic neuralgia. J. Pain Symptom Manage. 7 (1992) 320-323
7. Gupta A., Gartner J.J., Sethupathy P., Hatzigeorgiou A.G., and Fraser N.W. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442 (2006) 82-85
8. Hall A.K., Dinsio K.J., and Cappuzzello J. Skin cell induction of calcitonin gene-related peptide in embryonic sensory neurons in vitro involves activin. Dev. Biol. 229 (2001) 263-270
9. Hamza M.A., Higgins D.M., and Ruyechan W.T. Herpes simplex virus type-1 latency inhibits dendritic growth in sympathetic neurons. Neurobiol. Dis. 24 (2006) 367-373
10. Kent J.R., and Fraser N.W. The cellular response to herpes simplex virus type 1 (HSV-1) during latency and reactivation. J. Neurovirol. 11 (2005) 376-383
11. Kramer M.F., Cook W.J., Roth F.P., Zhu J., Holman H., Knipe D.M., and Coen D.M. Latent herpes simplex virus infection of sensory neurons alters neuronal gene expression. J. Virol. 77 (2003) 9533-9541
12. Krohel G.B., Richardson J.R., and Farrell D.F. Herpes simplex neuropathy. Neurology 26 (1976) 596-597
13. Lecci A., and Maggi C.A. Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases. Expert. Opin. Ther. Targets 7 (2003) 343-362
14. Pennefather J.N., Lecci A., Candenas M.L., Patak E., Pinto F.M., and Maggi C.A. Tachykinins and tachykinin receptors: a growing family. Life Sci. 74 (2004) 1445-1463
15. Perng G.C., Jones C., Ciacci-Zanella J., Stone M., Henderson G., Yukht A., Slanina S.M., Hofman F.M., Ghiasi H., Nesburn A.B., and Wechsler S.L. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287 (2000) 1500-1503
16. Takasaki I., Sasaki A., Andoh T., Nojima H., Shiraki K., and Kuraishi Y. Effects of analgesics on delayed postherpetic pain in mice. Anesthesiology 96 (2002) 1168-1174
17. Thompson R.L., and Sawtell N.M. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J. Virol. 71 (1997) 5432-5440
18. Thompson R.L., and Sawtell N.M. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J. Virol. 75 (2001) 6660-6675
19. Warren K.G., Brown S.M., Wroblewska Z., Gilden D., Koprowski H., and Subak-Sharpe J. Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N. Engl. J. Med. 298 (1978) 1068-1069
20. Yoshikawa T., Hill J.M., Stanberry L.R., Bourne N., Kurawadwala J.F., and Krause P.R. The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J. Exp. Med. 184 (1996) 659-664